Endurance Competitive Rider and Goblet Cell Carcinoid Cancer Survivor Takes on New International Challenge
November 26, 2013
Battling goblet cell carcinoid cancer has not deterred Monica Grundmann from pursuing her dream as an endurance rider with her Morab stallion, Excalibur Legend. Next month Monica will represent Eastern Canada in the North American Team Challenge 160-km, a 24-hour Endurance Race in Florida, competing against Western Canada, the U.S. and Mexico. ““I have always and will continue to live each day as if it is my last - saying and doing the maximum,” says Monica. “Obviously my personal goals regarding my beloved stallion, his competitions and his legacy, are paramount for me. Together, he and I have achieved much more than I ever could have dreamed and I am extremely grateful for being blessed to have him.” Read more about Monica’s amazing accomplishments and her journey with a rare cancer.
Name Your NET Hero for NET Cancer Day 2013
November 7, 2013
Name Your NET Hero to mark Worldwide NET Cancer Awareness Day, November 10th. Send in a photo of your NET Hero, and a line or two describing why he or she is your hero. Be it your doctor, nurse, spouse, friend, partner, colleague, etc., or all of them, bring these people to the spotlight, make their names and faces recognized on a global scale! Read More
NET Cancer Day 2013 Webinar
November 7, 2013
In recognition of Worldwide NET Cancer Awareness Day on November 10, NorCal CarciNet is hosting a one-hour, free webinar. Here’s a great opportunity to hear from 3 of the leading specialists in carcinoid/NET cancer treatment on NET CANCER DAY: Professor Dr. Richard P. Baum, Bad Berka, Germany; Dr. Eric Liu, Vanderbilt University, Tennessee; and Dr. Thomas O’Dorisio, University of Iowa. Read More
Coming Soon -- New Feature on Find a Doctor List
August 15, 2013
The Carcinoid Cancer Foundation welcomes feedback from the carcinoid/NET community so that we can regularly update our website, providing the most sought-after and up-to-date information possible. Recently we were asked to add a feature to our Find a Doctor list, identifying which physicians take Medicare, Medicaid, and insurance. We have contacted all the doctors in the United States on our current list and are presently collecting this information and preparing it as a new component on the Find a Doctor list.
A Possible Cure for Neuroendocrine Cancer: Exciting Update!
June 21, 2013
Thanks to the enormously generous gift of about $2 million from Vincent Hamilton, founder and Chairman of the Board of Tethys Oil AB and the amazing iCancer campaign — the championing of the cause by Alexander Masters, Dominic Nutt and Liz Scarff in Europe and Catherine Cooling Davis in the United States – the oncolytic virus clinical trial at Uppsala University in Sweden is going to become a reality!! Read more
Neuroendocrine Cancer: Making Sense of the Disease
Carcinoid/NET Specialist Dr. Eric Liu to Speak in Dallas, Texas
May 31, 2013
"Neuroendocrine Cancer: Making Sense of the Disease" is a special presentation by Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville, Tennessee, scheduled for June 8 at Baylor Hospital, hosted by the Carcinoid Cancer Texas Survivors Support Group. For more information, CLICK HERE.
Carcinoid Survivor Thrives as Endurance Rider
May 24, 2013
Monica Grundmann, who was diagnosed with goblet cell carcinoid in 2012, thought she had entered her last competitive event in June 2012. She won that OCTRA-sponsored Stormont Competitive Trail Ride, and dedicated her ride to the Carcinoid Cancer Foundation and the Carcinoid Neuroendocrine Tumor Society of Canada. Fortunately, it was not her last competitive event! Read moreabout Monica and her Morab stallion, Excalibur Legend, as they plan for an international competition this September and her dream to enter the World Equestrian Games in Bromont, Quebec in 2018.
Carcinoid/Neuroendocrine Tumor Presentations at ASCO Annual Meeting
May 22, 2013
Twenty-six abstracts about carcinoid and other NETs will be presented at the 2013 ASCO (American Society of Clinical Oncology) Annual Meeting, to be held May 31 to June 4 in Chicago, Illinois. Cutting-edge scientific presentations and comprehensive educational content will be shared with more than 25,000 oncology professionals from a broad range of specialties, exploring the theme of the Meeting — "Building Bridges to Conquer Cancer." Click here for the carcinoid/NETs presentations.
Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program
May 22, 2013
Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June 9th in Vancouver, British Columbia, Canada. The “Patient Program” provides a unique opportunity to network with passionate advocates and leading experts in neuroendocrine tumors (NETs), lymphoma disease, and dementia. Read more